1. Chan, EH, Russell, JL, Williams, WG, et al. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 2005; 80: 1864–1870.
Google Scholar | Crossref | Medline | ISI2. Zuluaga, MT. Chylothorax after surgery for congenital heart disease. Curr Opin Pediatr 2012; 24: 291–294.
Google Scholar | Crossref | Medline | ISI3. Mery, CM, Moffett, BS, Khan, MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg 2014; 147: 678–686.
Google Scholar | Crossref | Medline4. Nadolski, G. Nontraumatic chylothorax: diagnostic algorithm and treatment options. Tech Vasc Interv Radiol 2016; 19: 286–290.
Google Scholar | Crossref | Medline5. Schroth, M, Meißner, U, Cesnjevar, R, et al. Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery. Pediatr Cardiol 2006; 27: 56–60.
Google Scholar | Crossref | Medline6. Rimensberger, PC, Müller-Schenker, B, Kalangos, A, et al. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998; 66: 253–254.
Google Scholar | Crossref | Medline | ISI7. Muniz, G, Hidalgo-Campos, J, Valdivia-Tapia, MDC, et al. Successful management of chylothorax with etilefrine: case report in 2 pediatric patients. Pediatrics 2018; 141: e20163309.
Google Scholar | Crossref | Medline8. Guillem, P, Papachristos, I, Peillon, C, et al. Etilefrine use in the management of post-operative chyle leaks in thoracic surgery. Interact Cardiovasc Thorac Surg 2004; 3: 156–160.
Google Scholar | Crossref | Medline9. Savla, JJ, Itkin, M, Rossano, JW, et al. Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 2017; 69: 2410–2422.
Google Scholar | Crossref | Medline10. Luo, Q, Zhao, W, Su, Z, et al. Risk factors for prolonged pleural effusion following total cavopulmonary connection surgery: 9 years' experience at Fuwai hospital. Front Pediatr 2019; 7: 456.
Google Scholar | Crossref | Medline11. Lo Rito, M, Al-Radi, OO, Saedi, A, et al. Chylothorax and pleural effusion in contemporary extracardiac fenestrated fontan completion. J Thorac Cardiovasc Surg 2018; 155: 2069–2077.
Google Scholar | Crossref | Medline12. Kim, G, Ko, H, Byun, JH, et al. Risk factors for prolonged pleural effusion after extracardiac fontan operation. Pediatr Cardiol 2019; 40: 1545–1552.
Google Scholar | Crossref | Medline13. Talwar, S, Agarwala, S, Mittal, CM, et al. Pleural effusions in children undergoing cardiac surgery. Ann Pediatr Cardiol 2010; 3: 58–64.
Google Scholar | Crossref | Medline14. Raatz, A, Schöber, M, Zant, R, et al. Risk factors for chylothorax and persistent serous effusions after congenital heart surgery. Eur J Cardiothorac Surg 2019; 56: 1162–1169.
Google Scholar | Crossref | Medline15. Perry, T, Bora, K, Bakar, A, et al. Non-surgical risk factors for the development of chylothorax in children after cardiac surgery – does fluid matter? Pediatr Cardiol 2020; 41: 41194–41200.
Google Scholar16. Yao, X, Abd Hamid, M, Sundaralingam, A, et al. Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases. Breathe (Sheff) 2020; 16: 200203.
Google Scholar | Crossref | Medline17. Gupta, M, Johann-Liang, R, Sison, CP, et al. Relation of early pleural effusion after pediatric open heart surgery to cardiopulmonary bypass time and systemic inflammation as measured by serum interleukin-6. Am J Cardiol 2001; 87: 1220–1223.
Google Scholar | Crossref | Medline | ISI18. Papa, A, Emdin, M, Passino, C, et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008; 395: 27–31.
Google Scholar | Crossref | Medline | ISI19. Sawant, AC, Adhikari, P, Narra, SR, et al. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J 2014; 21: 500–508.
Google Scholar | Crossref | Medline | ISI20. Paquissi, FC. The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease. Ther Clin Risk Manag 2016; 12: 851–860.
Google Scholar | Crossref | Medline21. Testoni, D, Hornik, CP, Neely, ML, et al. Best pharmaceuticals for children act pediatric trials network administrative core committee. Safety of octreotide in hospitalized infants. Early Hum Dev 2015; 91: 387–392.
Google Scholar | Crossref | Medline22. Corifact (factor XIII concentrate) dosing, indications, interactions, adverse effects, and more, https://reference.medscape.com/drug/corifact-factor-xiii-concentrate-human-999624 (accesssed 8 May 2020).
Google Scholar23. Kanda . Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013; 48: 452–458.
Google Scholar | Crossref | Medline | ISI24. Weedle, RC, Da Costa, M, Veerasingam, D, et al. The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. Ann Transl Med 2019; 7: 778.
Google Scholar | Crossref | Medline25. Forget, P, Khalifa, C, Defour, JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 2017; 10: 12.
Google Scholar | Crossref | Medline26. Azab, B, Camacho-Rivera, M, Taioli, E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 2014; 9: e112361.
Google Scholar | Crossref | Medline | ISI27. Goldstein, SA, Beshish, AG, Bush, LB, et al. Analysis of inflammatory cytokines in postoperative fontan pleural drainage. Pediatr Cardiol 2019; 40: 744–772.
Google Scholar | Crossref | Medline28. Sigurdardottir, S, Zapadka, TE, Lindstrom, SI, et al. Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability. Cell Immunol 2019; 341: 103921.
Google Scholar | Crossref | Medline29. Rahman, MT, Ghosh, C, Hossain, M, et al. IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: relevance for neuro-inflammatory diseases. Biochem Biophys Res Commun 2018; 507: 274–329.
Google Scholar | Crossref | Medline